Novartis pauses autoimmune cell therapy studies after deaths
TimesLive | 01.09.2026 13:00
Novartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late August after three patients died, the Wall Street Journal (WSJ) reported on Tuesday.
